Kevin C. Maki PhD, CLS, MNLA, FTOS, FAHA , Carol F. Kirkpatrick PhD, MPH, RDN, CLS, FNLA , Jaime Almandoz MD, MBA, MRCPI, FTOS
{"title":"JCL Roundtable: Prediabetes","authors":"Kevin C. Maki PhD, CLS, MNLA, FTOS, FAHA , Carol F. Kirkpatrick PhD, MPH, RDN, CLS, FNLA , Jaime Almandoz MD, MBA, MRCPI, FTOS","doi":"10.1016/j.jacl.2025.02.019","DOIUrl":null,"url":null,"abstract":"<div><div>Prediabetes affects more than 1 in 3 adults in the United States and is associated with increased risks of type 2 diabetes, cardiovascular diseases, chronic kidney disease, and dementia. Excess adiposity is the strongest risk factor for prediabetes, and can contribute to several other cardiometabolic risk factors, such as dyslipidemia and insulin resistance. This <em>Journal of Clinical Lipidology</em> Roundtable presents a conversation between Drs Jaime P. Almandoz, Carol F. Kirkpatrick, and Kevin C. Maki, who discussed lifestyle and pharmacologic interventions for the management of prediabetes and the prevention of associated health risks. The discussion highlights the importance of interventions for addressing excess adiposity in those with prediabetes, including lifestyle, pharmacotherapy, and metabolic surgery, along with involving patients in shared decision-making conversations to identify, implement, and maintain an effective treatment plan.</div></div>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":"19 3","pages":"Pages 404-411"},"PeriodicalIF":4.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933287425000534","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Prediabetes affects more than 1 in 3 adults in the United States and is associated with increased risks of type 2 diabetes, cardiovascular diseases, chronic kidney disease, and dementia. Excess adiposity is the strongest risk factor for prediabetes, and can contribute to several other cardiometabolic risk factors, such as dyslipidemia and insulin resistance. This Journal of Clinical Lipidology Roundtable presents a conversation between Drs Jaime P. Almandoz, Carol F. Kirkpatrick, and Kevin C. Maki, who discussed lifestyle and pharmacologic interventions for the management of prediabetes and the prevention of associated health risks. The discussion highlights the importance of interventions for addressing excess adiposity in those with prediabetes, including lifestyle, pharmacotherapy, and metabolic surgery, along with involving patients in shared decision-making conversations to identify, implement, and maintain an effective treatment plan.
在美国，超过三分之一的成年人患有前驱糖尿病，并与2型糖尿病、心血管疾病、慢性肾病和痴呆的风险增加有关。过度肥胖是糖尿病前期最强的危险因素，并可能导致其他一些心脏代谢危险因素，如血脂异常和胰岛素抵抗。本临床脂质学圆桌会议杂志介绍了博士之间的对话。Jaime P. Almandoz, Carol F. Kirkpatrick和Kevin C. Maki，他们讨论了生活方式和药物干预对糖尿病前期管理和相关健康风险的预防。讨论强调了解决糖尿病前期患者过度肥胖的干预措施的重要性，包括生活方式、药物治疗和代谢手术，以及让患者参与共同决策对话，以确定、实施和维持有效的治疗计划。
期刊介绍：
Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner.
Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
